NCT00646230 2023-04-07
IV Fenretinide
Children's Hospital Los Angeles
Phase 1 Completed
Clinical Trials
12 trialsNCT00102635 2018-11-15
4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC)
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00004154 2018-11-08
Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer
M.D. Anderson Cancer Center
Phase 3 Completed
NCT01479192 2018-11-07
Fenretinide in Healthy Young Women at Genetic and Familial Risk
European Institute of Oncology
Phase 3 Terminated
NCT00006471 2018-11-01
Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00006080 2018-06-27
Fenretinide in Treating Patients With Recurrent Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00003250 2014-04-11
Fenretinide in Treating Patients With Solid Tumors
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00004161 2013-04-12
Fenretinide in Treating Patients With Leukoplakia of the Mouth
University of Alabama at Birmingham
Phase 2 Completed
NCT00011973 2013-04-05
Chemotherapy in Treating Patients With Advanced Kidney Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00003099 2012-07-30
Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00005819 2010-06-11
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00098800 2010-03-24
Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries
University of Arizona
Phase NA Completed